A case of malignant transformation of a serous borderline ovarian tumor effectively treated with BRAF/MEK inhibitor combination

• Autores principales: Manrose Singh (Autor), Samantha Cornwell (Autor), Ariel Shaddaie (Autor), Leah Wachsmuth (Autor), Ashwin Ragupathi (Autor), Leonidas Salichos (Autor), Sandra Nissel-Horowitz (Autor), Rajasree Roy (Autor), Maria Plummer (Autor), Dong Zhang (Autor), Bhoomi Mehrotra (Autor)
• Formato: Libro
• Publicado: Elsevier, 2024-08-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

We describe a patient diagnosed with a metastatic adenocarcinoma of Müllerian origin, harboring a BRAF V600E mutation, ten years after being treated for a serous borderline tumor (SBOT). While BRAF mutations in the setting of SBOTs are common, they have been typically associated with a low chance o...